Our results confirmed that the lack of endogenous AnxA1 is very detrimental to the progression of experimental colitis: AnxA1−/− mice had much worse clinical and histological outcomes, fewer intestinal regulatory T cell (Treg) counts, and a 25% mortality rate compared to WT mice. Here, ANXA1 is linked to colitis.